Short Stature Diagnosis and Referral

The “360° GH in Europe” meeting, which examined various aspects of GH diseases, was held in Lisbon, Portugal, in June 2016. The Merck KGaA (Germany) funded meeting comprised three sessions entitled “Short Stature Diagnosis and Referral,” “Optimizing Patient Management,” and “Managing Transition.” Ea...

Full description

Bibliographic Details
Main Authors: Mohamad Maghnie, José I. Labarta, Ekaterina Koledova, Tilman R. Rohrer
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fendo.2017.00374/full
_version_ 1818467035328282624
author Mohamad Maghnie
José I. Labarta
Ekaterina Koledova
Tilman R. Rohrer
author_facet Mohamad Maghnie
José I. Labarta
Ekaterina Koledova
Tilman R. Rohrer
author_sort Mohamad Maghnie
collection DOAJ
description The “360° GH in Europe” meeting, which examined various aspects of GH diseases, was held in Lisbon, Portugal, in June 2016. The Merck KGaA (Germany) funded meeting comprised three sessions entitled “Short Stature Diagnosis and Referral,” “Optimizing Patient Management,” and “Managing Transition.” Each session had three speaker presentations, followed by a discussion period, and is reported as a manuscript, authored by the speakers. The first session examined current processes of diagnosis and referral by endocrine specialists for pediatric patients with short stature. Requirements for referral vary widely, by country and by patient characteristics such as age. A balance must be made to ensure eligible patients get referred while healthcare systems are not over-burdened by excessive referrals. Late referral and diagnosis of non-GH deficiency conditions can result in increased morbidity and mortality. The consequent delays in making a diagnosis may compromise the effectiveness of GH treatment. Algorithms for growth monitoring and evaluation of skeletal disproportions can improve identification of non-GH deficiency conditions. Performance and validation of guidelines for diagnosis of GH deficiency have not been sufficiently tested. Provocative tests for investigation of GH deficiency remain equivocal, with insufficient information on variations due to patient characteristics, and cutoff values for definition differ not only by country but also by the assay used. When referring and diagnosing causes of short stature in pediatric patients, clinicians need to rely on many factors, but the most essential is clinical experience.
first_indexed 2024-04-13T21:04:16Z
format Article
id doaj.art-031b7c77ae274d3da698bb0e424a8708
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T21:04:16Z
publishDate 2018-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-031b7c77ae274d3da698bb0e424a87082022-12-22T02:30:02ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922018-01-01810.3389/fendo.2017.00374298133Short Stature Diagnosis and ReferralMohamad Maghnie0José I. Labarta1Ekaterina Koledova2Tilman R. Rohrer3Department of Pediatrics, IRCCS Children’s Hospital Giannina Gaslini, University of Genoa, Genoa, ItalyEndocrinology Unit, Children’s Hospital Miguel Servet, University of Zaragoza, Zaragoza, SpainGlobal Medical Affairs, Merck KGaA, Darmstadt, GermanyDepartment of Pediatrics, Saarland University Medical Center, Homburg, GermanyThe “360° GH in Europe” meeting, which examined various aspects of GH diseases, was held in Lisbon, Portugal, in June 2016. The Merck KGaA (Germany) funded meeting comprised three sessions entitled “Short Stature Diagnosis and Referral,” “Optimizing Patient Management,” and “Managing Transition.” Each session had three speaker presentations, followed by a discussion period, and is reported as a manuscript, authored by the speakers. The first session examined current processes of diagnosis and referral by endocrine specialists for pediatric patients with short stature. Requirements for referral vary widely, by country and by patient characteristics such as age. A balance must be made to ensure eligible patients get referred while healthcare systems are not over-burdened by excessive referrals. Late referral and diagnosis of non-GH deficiency conditions can result in increased morbidity and mortality. The consequent delays in making a diagnosis may compromise the effectiveness of GH treatment. Algorithms for growth monitoring and evaluation of skeletal disproportions can improve identification of non-GH deficiency conditions. Performance and validation of guidelines for diagnosis of GH deficiency have not been sufficiently tested. Provocative tests for investigation of GH deficiency remain equivocal, with insufficient information on variations due to patient characteristics, and cutoff values for definition differ not only by country but also by the assay used. When referring and diagnosing causes of short stature in pediatric patients, clinicians need to rely on many factors, but the most essential is clinical experience.http://journal.frontiersin.org/article/10.3389/fendo.2017.00374/fullgrowth hormoneshort staturediagnosisreferralpatient management
spellingShingle Mohamad Maghnie
José I. Labarta
Ekaterina Koledova
Tilman R. Rohrer
Short Stature Diagnosis and Referral
Frontiers in Endocrinology
growth hormone
short stature
diagnosis
referral
patient management
title Short Stature Diagnosis and Referral
title_full Short Stature Diagnosis and Referral
title_fullStr Short Stature Diagnosis and Referral
title_full_unstemmed Short Stature Diagnosis and Referral
title_short Short Stature Diagnosis and Referral
title_sort short stature diagnosis and referral
topic growth hormone
short stature
diagnosis
referral
patient management
url http://journal.frontiersin.org/article/10.3389/fendo.2017.00374/full
work_keys_str_mv AT mohamadmaghnie shortstaturediagnosisandreferral
AT joseilabarta shortstaturediagnosisandreferral
AT ekaterinakoledova shortstaturediagnosisandreferral
AT tilmanrrohrer shortstaturediagnosisandreferral